nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinolazepam—GABRR3—nerve—hypothyroidism	0.131	0.135	CbGeAlD
Cinolazepam—GABRR2—nerve—hypothyroidism	0.114	0.117	CbGeAlD
Cinolazepam—GABRR1—nerve—hypothyroidism	0.109	0.113	CbGeAlD
Cinolazepam—GABRG3—pituitary gland—hypothyroidism	0.0356	0.0368	CbGeAlD
Cinolazepam—GABRB1—pituitary gland—hypothyroidism	0.0275	0.0284	CbGeAlD
Cinolazepam—GABRG3—testis—hypothyroidism	0.0263	0.0272	CbGeAlD
Cinolazepam—GABRR1—testis—hypothyroidism	0.0251	0.0259	CbGeAlD
Cinolazepam—GABRP—pituitary gland—hypothyroidism	0.0247	0.0255	CbGeAlD
Cinolazepam—GABRR2—cerebellum—hypothyroidism	0.024	0.0248	CbGeAlD
Cinolazepam—GABRE—heart—hypothyroidism	0.0225	0.0233	CbGeAlD
Cinolazepam—GABRA3—thyroid gland—hypothyroidism	0.022	0.0227	CbGeAlD
Cinolazepam—GABRD—testis—hypothyroidism	0.0218	0.0225	CbGeAlD
Cinolazepam—GABRG2—pituitary gland—hypothyroidism	0.0208	0.0215	CbGeAlD
Cinolazepam—GABRA5—testis—hypothyroidism	0.0202	0.0209	CbGeAlD
Cinolazepam—GABRD—cerebellum—hypothyroidism	0.0201	0.0208	CbGeAlD
Cinolazepam—GABRG1—cerebellum—hypothyroidism	0.0194	0.02	CbGeAlD
Cinolazepam—GABRB3—heart—hypothyroidism	0.0191	0.0197	CbGeAlD
Cinolazepam—GABRA3—testis—hypothyroidism	0.0188	0.0194	CbGeAlD
Cinolazepam—GABRE—pituitary gland—hypothyroidism	0.0188	0.0194	CbGeAlD
Cinolazepam—GABRB1—cerebellum—hypothyroidism	0.0188	0.0194	CbGeAlD
Cinolazepam—GABRA2—adrenal gland—hypothyroidism	0.017	0.0175	CbGeAlD
Cinolazepam—GABRE—adrenal gland—hypothyroidism	0.0168	0.0174	CbGeAlD
Cinolazepam—GABRB3—gonad—hypothyroidism	0.0164	0.0169	CbGeAlD
Cinolazepam—GABRE—thyroid gland—hypothyroidism	0.0162	0.0168	CbGeAlD
Cinolazepam—GABRB3—pituitary gland—hypothyroidism	0.016	0.0165	CbGeAlD
Cinolazepam—GABRE—female gonad—hypothyroidism	0.0157	0.0162	CbGeAlD
Cinolazepam—GABRB2—testis—hypothyroidism	0.0153	0.0159	CbGeAlD
Cinolazepam—GABRB2—cerebellum—hypothyroidism	0.0142	0.0146	CbGeAlD
Cinolazepam—GABRG2—cerebellum—hypothyroidism	0.0142	0.0146	CbGeAlD
Cinolazepam—GABRE—testis—hypothyroidism	0.0139	0.0144	CbGeAlD
Cinolazepam—GABRB3—thyroid gland—hypothyroidism	0.0138	0.0142	CbGeAlD
Cinolazepam—GABRA2—cerebellum—hypothyroidism	0.0129	0.0134	CbGeAlD
Cinolazepam—GABRA1—cerebellum—hypothyroidism	0.0125	0.0129	CbGeAlD
Cinolazepam—GABRB3—testis—hypothyroidism	0.0118	0.0122	CbGeAlD
Cinolazepam—GABRB3—liver—hypothyroidism	0.0111	0.0115	CbGeAlD
Cinolazepam—GABRB3—cerebellum—hypothyroidism	0.0109	0.0112	CbGeAlD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000813	0.0254	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000776	0.0242	CbGpPWpGaD
Cinolazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000697	0.0218	CbGpPWpGaD
Cinolazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000665	0.0208	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000643	0.0201	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000639	0.02	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000629	0.0197	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—SLC5A7—hypothyroidism	0.000623	0.0195	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—SLC5A7—hypothyroidism	0.000594	0.0186	CbGpPWpGaD
Cinolazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000548	0.0171	CbGpPWpGaD
Cinolazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000539	0.0169	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000538	0.0168	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000524	0.0164	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000522	0.0163	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000513	0.016	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000504	0.0157	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000501	0.0156	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.0005	0.0156	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000492	0.0154	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—SLC5A7—hypothyroidism	0.000489	0.0153	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—SLC5A7—hypothyroidism	0.000482	0.0151	CbGpPWpGaD
Cinolazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000461	0.0144	CbGpPWpGaD
Cinolazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000448	0.014	CbGpPWpGaD
Cinolazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00044	0.0137	CbGpPWpGaD
Cinolazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000432	0.0135	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00043	0.0134	CbGpPWpGaD
Cinolazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000429	0.0134	CbGpPWpGaD
Cinolazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000422	0.0132	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000415	0.0129	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.000412	0.0129	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000412	0.0129	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000406	0.0127	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—NEFL—hypothyroidism	0.000402	0.0125	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.0004	0.0125	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.000393	0.0123	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.000386	0.0121	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—SLC5A7—hypothyroidism	0.000384	0.012	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—NEFL—hypothyroidism	0.000383	0.012	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.000377	0.0118	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000368	0.0115	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000347	0.0108	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000337	0.0105	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000335	0.0105	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000331	0.0103	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000329	0.0103	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000325	0.0101	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000323	0.0101	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00032	0.00998	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000317	0.0099	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—NEFL—hypothyroidism	0.000315	0.00985	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—NEFL—hypothyroidism	0.000311	0.00971	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000278	0.00867	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000277	0.00865	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—NEFL—hypothyroidism	0.000266	0.00829	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000265	0.00827	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000263	0.00822	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000259	0.0081	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—NEFL—hypothyroidism	0.000258	0.00806	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—NEFL—hypothyroidism	0.000253	0.00791	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—NEFL—hypothyroidism	0.000249	0.00778	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—NEFL—hypothyroidism	0.000247	0.00772	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000243	0.00759	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000222	0.00692	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000218	0.00681	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000215	0.00672	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000215	0.00671	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—VAV3—hypothyroidism	0.000213	0.00665	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000212	0.00663	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000211	0.0066	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000208	0.00649	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000206	0.00645	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000203	0.00633	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000184	0.00573	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000178	0.00557	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000177	0.00553	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000175	0.00547	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000172	0.00538	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000171	0.00534	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000168	0.00524	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000165	0.00516	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000147	0.00458	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000134	0.00418	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000128	0.00399	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000105	0.00329	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000105	0.00329	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000104	0.00324	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000101	0.00314	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.85e-05	0.00277	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.6e-05	0.00269	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.45e-05	0.00264	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.3e-05	0.00259	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—AVP—hypothyroidism	8.28e-05	0.00259	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.25e-05	0.00258	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—AVP—hypothyroidism	8.16e-05	0.00255	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.1e-05	0.00253	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.08e-05	0.00221	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.97e-05	0.00218	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	6.77e-05	0.00212	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	6.65e-05	0.00208	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.54e-05	0.00204	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—AVP—hypothyroidism	6.49e-05	0.00203	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.38e-05	0.00199	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.57e-05	0.00174	CbGpPWpGaD
